Literature DB >> 18450655

Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study.

James J Newham1, Simon H Thomas, Karine MacRitchie, Patricia R McElhatton, R Hamish McAllister-Williams.   

Abstract

BACKGROUND: The effects of in utero exposure to atypical antipsychotics on infant birth weight are unknown. AIMS: To determine whether atypical and typical antipsychotics differ in their effects on birth weight after maternal exposure during pregnancy.
METHOD: Prospective data on gestational age and birth weight collected by the National Teratology Information Service for infants exposed to typical (n=45) and atypical (n=25) antipsychotics was compared with data for a reference group of infants (n=38).
RESULTS: Infants exposed to atypical antipsychotics had a significantly higher incidence of large for gestational age (LGA) than both comparison groups and a mean birth weight significantly heavier than those exposed to typical antipsychotics. In contrast those exposed to typical antipsychotics had a significantly lower mean birth weight and a higher incidence of small for gestational age infants than the reference group.
CONCLUSIONS: In utero exposure to atypical antipsychotic drugs may increase infant birth weight and risk of LGA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18450655     DOI: 10.1192/bjp.bp.107.041541

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  26 in total

1.  Neonatal hypoglycaemia following maternal olanzapine therapy during pregnancy: a case report.

Authors:  Melissa Rowe; Bharath A Gowda; David Taylor; Simon Hannam; Louise M Howard
Journal:  Ther Adv Psychopharmacol       Date:  2012-12

Review 2.  Antipsychotic therapy during early and late pregnancy. A systematic review.

Authors:  Salvatore Gentile
Journal:  Schizophr Bull       Date:  2008-09-11       Impact factor: 9.306

3.  Prenatal antipsychotic exposure and neuromotor performance during infancy.

Authors:  Katrina C Johnson; Jamie L LaPrairie; Patricia A Brennan; Zachary N Stowe; D Jeffrey Newport
Journal:  Arch Gen Psychiatry       Date:  2012-08

4.  Second-generation antipsychotics and pregnancy complications.

Authors:  Maria Ellfolk; Maarit K Leinonen; Mika Gissler; Anna-Maria Lahesmaa-Korpinen; Leena Saastamoinen; Marja-Leena Nurminen; Heli Malm
Journal:  Eur J Clin Pharmacol       Date:  2019-11-03       Impact factor: 2.953

5.  Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries.

Authors:  Sengwee Toh; Qian Li; T Craig Cheetham; William O Cooper; Robert L Davis; Sascha Dublin; Tarek A Hammad; De-Kun Li; Pamala A Pawloski; Simone P Pinheiro; Marsha A Raebel; Pamela E Scott; David H Smith; William V Bobo; Jean M Lawrence; Inna Dashevsky; Katherine Haffenreffer; Lyndsay A Avalos; Susan E Andrade
Journal:  Arch Womens Ment Health       Date:  2013-02-07       Impact factor: 3.633

Review 6.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

Review 7.  Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects.

Authors:  Megan Galbally; Martien Snellen; Josephine Power
Journal:  Ther Adv Drug Saf       Date:  2014-04

8.  Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study.

Authors:  Mei Peng; Keming Gao; Yiling Ding; Jianjun Ou; Joseph R Calabrese; Renrong Wu; Jingping Zhao
Journal:  Psychopharmacology (Berl)       Date:  2013-04-05       Impact factor: 4.530

Review 9.  The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review.

Authors:  Per Damkier; Poul Videbech
Journal:  CNS Drugs       Date:  2018-04       Impact factor: 5.749

10.  More questions than answers! Clinical dilemmas in psychopharmacology in pregnancy and lactation.

Authors:  Geetha Desai; Girish N Babu; Ravi P Rajkumar; Prabha S Chandra
Journal:  Indian J Psychiatry       Date:  2009-01       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.